Smart Solutions for Sustainable Pharma Packaging: Shaping the Future of Barrier Innovations

The pharmaceutical industry is highly committed to advancing sustainability strategies while maintaining the highest standards of product protection, regulatory compliance, and patient safety. Packaging plays an important role in ensuring medicines remain safe, effective, and accessible to patients worldwide. As sustainability gains momentum across the industry, companies are looking for solutions that lower environmental impact while continuing to meet strict regulatory and safety requirements. Among these efforts, there is a growing focus on packaging alternatives that align with corporate commitments and evolving industry expectations. Liveo Research is actively driving this transformation through sustainable packaging solutions and strategic collaborations. In 2024, the Liveo Research One-Material Blister (OMB®) in PET became the first of its kind to reach the market, launched with Bayer as a milestone for sustainable blister packaging. Building on this success, Liveo Research is now expanding into new barrier alternatives, laying the groundwork for future mid- to high-barrier platforms.